Marijuana-Laced Brownies: Behavioral Effects, Physiologic Effects, 9 ~1 and Urinalysis in Humans Following Ingesbon

Transcription

1 I Marijuana-Laced Brownies: Behavioral Effects, Physiologic Effects, 9 ~1 and Urinalysis in Humans Following Ingesbon Edward J. Cone* and Rolley E. Johnson National Institute on Drug Abuse, Addiction Research Center, Baltimore, Maryland Buddha D. Paul, Leroy D. Mell, and John Mitchell Navy Drug Screening Laborato~ S-33, Naval Air Station, Norfolk, Virginia Abstract Five drug-free male subjects ingested marijuana-laced brownies In a double-blind crossover study designed to test for behavioral effects, physiologic effects, and urinary cannabinold metabolites produced as e result of consumption of marijuana plant material cooked in foodstuff. On three separate occasions, each subject consumed two brownies which contained 1.6 g of marijuana plant material. Placebo marijuana plant material (0% THC) wee mixed with marijuana plant material (2.8% THC) so that each subject ingested equivalent marijuana plant material of 0, 1, and 2 marijuana cigarettes (2.8% THC). Subjects scored significantly higher on behavioral measures after consumption of brownies containing THC than with placebo; however, the effects were slow to appear and variable. Peak effects occurred 2.5 to 3.5 h after dosing. Modest changes in pulse and blood pressure also were noted. Urinalyses by EMIT d.e.u, assay and Abuscreen RIA for cannabinoide and GC/MS assay for THCCOOH indicated that substantial amounts of marijuana-related metabolltes were excreted over a period of 3 to 14 days. No positives were produced as s result of ingestion of placebo brownies. Introduction Although there have been numerous studies on the metabolism, disposition, and excretion of marijuana (1) and A'-tetrahydro - cannabinol (THC) (2) after smoking, there is a paucity of data on the oral administration of marijuana in foodstuff. Law, et al. (3) reported detection of cannabinoid metabolites in blood for up to five days and in urine for up to twelve days after a single oral dose of cannabis resin in a meat sandwich. Also, a number of studies have reported on the oral administration of THC, the major active ingredient of marijuana (4,5), but similar studies regarding the ingestion of marijuana plant material have not appeared. We have assessed the behavioral, physiological, and urinary excretion profile of cannabinoid metabolites in healthy, male volunteers who had consumed brownies laced with marijuana. On three separate test days, subjects ate two brownies containing " Author to whom request for reprints should be addressed. marijuana plant material equivalent to one of the following test doses: two standard marijuana cigarettes each containing 2.8~ THC; one standard marijuana cigarette ( THC) and one placebo marijuana cigarette (0070 THC); and two placebo marijuana cigarettes (007o THC). All urine specimens were collected throughout the study and were analyzed for cannabinoids by EMIT ~ d.a.u, assay, Abuscreen radioimmunoassay (RIA) and for 1 l-nor-a'-thc-9-carboxylic acid (THCCOOH) by GC/MS. This report describes the behavioral and physiologic effects produced by consumption of marijuana-laced brownies in five human subjects and details individual excretion patterns of cannabinoid metabolites. Experimental Subleets The five volunteer subjects (designated H, K, L, M, N) who participated in the study were healthy, drug-free males with a history of marijuana use. Prior to the study, subjects were required to present urine specimens free of cannabinoid metabolites by EMIT d.a.u, assay (20 ng/ml cutoff) for a period of four days. Subject characteristics and marijuana history are summarized in Table I. The study was conducted under the guidelines for the protection of human subjects, and each volunteer gave informed consent. During the study all subjects were housed on a closed research ward under close surveillance. Materials and methods Marijuana cigarettes used in these studies were provided by the Research Technology Branch, National Institute on Drug Abuse. Active marijuana cigarettes contained 2.8~ (by weight) total THC. Cannabinoid analysis data supplied with the cigarettes indicated that they contained the following constituents: 1.15~ THC, 1.70~ THC acid B, 0.34~ cannabinol, 0.32~ cannabichromene, and cannabinol. Placebo marijuana cigarettes contained 0070 total THC. Preparation of marijuana brownies. Brownies were prepared with Duncan Hines Double Fudge Brownie Mix. They were prepared according to the manufacturer's instructions but contained marijuana plant material which was added initially to the dry ingredients. After mixing the dry ingredients thoroughly, 50 ml of tap water and one large egg were added and the wet Reproduction (photocopying) of editorial content of this journal is prohibited without publisher's permission. 169

2 mixture was blended thoroughly by 50 strokes of a wooden spoon. A tared pyrex dish (8 in. x 8 in.) was greased with a light coat of Crisco TM and the marijuana-brownie mixture was added. The dish was cooked in a 350~ preheated oven for 30 rain. After cooling, the net brownie mixture weight was determined. The cooked brownie cake was divided into 9 parts, each weighing approximately 55 g. Four doses were made, each containing two brownies. The total weight of each dose was adjusted to match that of the actual brownie dish net weight x 2/9. The inside brownie was used for making the weight adjustments. All doses of marijuana brownies contained a total of 1.6 g of marijuana plant material. The amount of active marijuana in each dose was equivalent to one of the following: 2 standard 800-mg marijuana cigarettes (2.8% THC); 1 standard 800-mg marijuana cigarette (2.8~ THC) and 1 standard 800-mg placebo cigarette (007o THC); and 2 standard 800-mg placebo cigarettes (0% THC). These doses were attained by initially adding 7.2 g of marijuana plant material which contained the following respective combinations: 7.2 g of marijuana cigarette leaf (2.807o THC); 3.6 g of marijuana cigarette leaf (2.8% THC) and 3.6 g of placebo cigarette leaf (007o THC); and 7.2 g of placebo cigarette leaf. The standardized brownie doses were stored in the freezer until administered. Study design. Each subject received single treatments of the following three doses of marijuana brownies assigned in random order under double-blind conditions: 2 brownies containing the total equivalent plant material of 2 marijuana cigarettes (2.807o THC); two brownies containing the equivalent of 1 marijuana cigarette (2.807o THC) and 1 placebo cigarette (007o THC); and 2 brownies containing the total equivalent plant material of 2 placebo cigarettes (0% THC). The doses were administered at 0830 on the test days. Subjects were allowed to drink liquids (coffee, milk, or water) and solid foods as requested throughout their stay on the research ward. Test days were separated by a minimum of 3 nontest days. Urines were collected after each test until cannabinoid-free urines were obtained for a minimum of 3 days. Behavioral and physiologic measurements. All behavioral and physiologic measures were made at 1.0 h (0730) and 0.5 h (0800) before drug administration (0830) and after drug administration at 1.0 h (0930), 2.0 h (1030), 3.0 h (1130), 4.0 h (1230), 6.0 h (1430), 8.0 h (1630), and 12.0 h (2030). Behavioral effects were measured in the manner reported previously (7) with the Single Dose Questionnaire, subscales of the Addiction Research Center Inventory (ARCI), and a Visual Analog Scale (VAS). Physiologic measures of standing pulse, standing systolic and diastolic blood pressure, supine pulse, supine systolic and diastolic blood pressure, pupils, and respiration were made. Both the behavioral and physiologic responses were analyzed as differences between responses after drug administration and the mean of control Table I. Subject Characteristics Use History and Marijuana Marijuana history Sub- Age Weight Duration Highest freject (years) (kg) Last use of use quency of use H within 6 mo over 10 yr weekly K within 6 mo over 10 yr daily L within 6 mo over 10 yr M within 6 rno over 10 yr daily several/week N within 6 mo over 10 p' weekly responses prior to drug administration. The area under the time-action curve (AUC) for the response over time was calculated by the trapezoidal rule. If analysis of variance of the AUC between test doses was significant (p<0.05), a Tukey test was applied to determine whether significant differences in mean responses occurred on test days for which active marijuana doses were administered compared to placebo test days. Sample collections. All urines were collected (ad libitum) while subjects were housed on the clinical ward. In addition, subjects were asked to urinate at 0800, 1600, and 2400 h each day. Specimens were collected in subject-coded polypropylene beakers. The time, date, subject code letter, and approximate volume of each specimen were recorded by a research assistant at the time of collection. On a daily basis, all urines were processed by measuring volume, specific gravity, and performing EMIT d.a.u, analysis for cannabinoid metabolites; the remainder of the specimen was transferred to polypropylene screw-capped bottles and frozen until time of analyses by RIA and GC/MS. Chemical analyses. All urines were analyzed daily for cannabinoids by EMIT ~ d.a.u, assay (Syva Company). The main instrument components consisted of a Syva Autocarousel, a Model S-l I 1 Spectrophotometer, and a Syva Lab Processor. Urines were initially screened with the EMIT d.a.u. Cannabinoid 20 Assay. All samples with rates equal to or greater than the 20 ng/ml calibrator rate were redetermined and the background (blank) rate was measured. If the average rate of the duplicates minus blank equaled or exceeded the 20 ng/ml cutoff rate, the sample was designated positive for cannabinoids (EMIT 20 Assay). Urines also were analyzed quantitatively for THCCOOH by gas chromatography/mass spectrometry (GC/MS) (6) and by RIA (Abuscreen, Roche Diagnostic Systems) for cannabinoid metabolites as previously described (10). The lower limit of sensitivity for l l-nor-a%thc-9-carboxylic acid by GC/MS was 2 ng/ml and by RIA was 5 ng/ml. All RIA data are expressed as ng/ml equivalents of THCCOOH. Results Behavioral and physiologic effects After the ingestion of marijuana-laced brownies containing plant material equivalent to one and two marijuana cigarettes (2.80/0 THC), all five human subjects scored higher on all behavioral measures (ARCI subscales, Single Dose Questionnaire, and VAS, Table I1) than under placebo test conditions. ANOVA analyses of the AUC measures over a period of 11.5 h after ingestion indicated that a significant (p < 0.05) dose effect response was obtained on the Feel Drug, Liking, and Symptom scales. Application of the Tukey test to measures that tested significant further revealed significant differences (p < 0.05) in AUC measures between the two-marijuana-cigarette test dose and the one-marijuana-cigarette test dose on the Feel Drug and Liking scales and a significant difference (p < 0.05) between the one-marijuana-cigarette test dose and the placebo-marijuanacigarette test dose on the Liking scale. The onset of behavioral effects after the ingestion of marijuana-laced brownies was somewhat slow and variable. Although some subjects reported elevated behavioral measures 30 min after ingestion, the peak responses generally occurred 2.5 to 3.5 h after dosing (Figures IA, 1B, and 1C). These responses were 170

3 Journal of Analytical Toxicology. Vol. 12, July/August 1988 Table II. Area Under the Curve Measures (Mean Response-Time) After Administration of Marijuana Brownies Measure ARCl Subscales MAR LSD 1.00 PCAG O. 15 MBG Single Bose Questionnaire Feel Drug 2.70 Liking 2.20 Symptoms 2.60 Signs 4.30 Observer Liking 1.20 Drug Effect 0 VAS 2.40 Supine pulse Standing pulse Supine systolic BP 0.65 Standing systolic BP Supine diastolic 8P Standing diastolic BP Respiration 26.9 Pupils Different from placebo *" Different from one marijuana cigarette and placebo *** NS = not significant, Marijuana brownie dose Dose effect 1 2 significance Placebo cigarette cigarettes p NS*** NS NS " " 19.30" NS NS NS NS NS 25.7O NS NS NS NS NS NS NS prolonged and often continued to be above predrug measures through the end of the test session 11.5 h later. Clinical evaluation of the subjects on days following each test day indicated that the behavioral effects dissipated within 24 h of dosing. Elevations also occurred in physiologic measures of supine pulse (Figure I D), standing pulse, and supine systolic and diastolic blood pressure after administration of brownies containing plant material equivalent to two marijuana cigarettes; however, the changes generally were modest, that is, less than 20% from baseline, variable, and not significantly different from placebo by ANOVA analyses (Table I1). Responses on the remaining physiologic measures at all test doses were extremely variable and provided no dose-related trends upon graphical inspection. Urinalysis After administration of marijuana-laced brownies to the 5 subjects, urine specimens tested highly positive for cannabinoids by EMIT 20 Assay. Reaction rates consistently exceeded the medium calibrator (75 ng/ml) for the first urine collections. Generally, the rates continued to exceed the medium calibrator for a period of 1-2 days after dose administration and exceeded the low calibrator (20 ng/ml) for a considerably longer period of time (See Figure 2 for individual profiles). In contrast, no urines tested positive after administration of brownies laced with placebo marijuana plant material. Analysis of the individual cannabinoid excretion profiles is shown in Table I11, which displays the times between drug administration and the production of each subject's first negative urine specimen by EMIT 1.2" 1.0" A) FEEL DRUG BROWNE DOSE B) LIKING 0.8" 2 ~ 0.6" OA" 1 0.2" 0.0 i 1 i ! q VAS 20- D) PULSE W o U r & ~ 10 ~ o 0 o i I i i lo 12-10! v! 1! i Figure 1. Mean behavioral and physiological effects produced in five subjects after consumption of marijuana-laced brownies. Marijuana brownie content is shown in the inset. 1MJ CIG = brownie dose which contained plant material equivalent to one marijuana cigarette (2.8% THC) and one placebo cigarette (0% THC); 2MJ CIG = brownie dose which contained plant material equivalent to two marijuana cigarettes (2.8% THC). 171

4 assay and the times between drug administration and the production of each subject's last positive specimen by EMIT assay. Although detection times generally were longer after administration of the higher marijuana dose, there were some individual reversals in this trend, that is, time to first negative, subject H, and time to last positive, subject L. Mean times _+ SE to first negative (20-ng/mL cutoff) were 58.4_ h and 81.6_+23.2 h and mean times _+ SE to last positive were h and 142.6_+34.3 h after administration of the low and high marijuana brownie doses respectively. When a higher cutoff for EMIT assay was employed, 75 ng/ml, both the time to first negative and time to last positive measures decreased by approximately 40% for both marijuana brownie doses. Quantitative analysis of individual urine specimens for cannabinoid metabolites by Abuscreen RIA also are shown in Figure 2. Specimens that exceeded the 100 ng/ml THCCOOH calibrator were not reassayed and are reported as greater than 100 ng/mg THCCOOH equivalents. With an arbitrary cutoff of 10 ng/ml of THCCOOH equivalents, specimens generally tested positive for longer periods than by EM1T 20 Assay (20-ng/mL cutoff). Mean times _+ SE to first negative were 98.8 _ h and _ h and mean times + SE to last positive were 140.3_+31.9 h and 190.3_+42.7 h after administration of the low and high marijuana brownie doses, respectively (Table IV). GC/MS assay of total THCCOOH (free and conjugated) in urine specimens after ingestion of marijuana-laced brownies 5eo ~ ~eo e ~ ~oe ~ ioo SUBJECT H /, MARIJUANA BRC, WNIES H I MJ CIG EQUIV DOSE 2 MJ GIG UOU~V DOSE o m~ o~,o ~ c g g g 55e i 4 ' ", } I,,,, DA~S F~LJBJLCT k sc~s 5OC ~oo 1 ao- A ~ *se. i... ; Figure 2. Urinary excretion profiles of subjects H, K, L, M, and N after consumption of marijuana-laced brownies. Times of dose administration are indicated by arrows. Open symbols indicate control measures obtained prior to dosing. For RIA and GC/MS analyses, samples which assayed as 0 ng/ml concentration of cannabinoid metabolites were not plotted except to connect adjoining points. For RIA analyses, samples which exceeded 100 ng/ml THCCOOH equivalents were plotted as greater than 100 ng/ml and are connected by dotted lines. 172

5 ~ 40O 9 ~00 0 I'- IOO GCIMS o ~'ff", ~, SUBJECT L MARIJUANA BROWNIES H I M, (,IO EOL-I'~,~OSf ~. 2 MJ C G EQUIV DOSE ~ T ~ i ~ I 1 ~ I T T RIA >100 -~ I....,~, ~ o,,,,,-,~,-"* ~,~,,, EMIT RATE 5OO 4O0 300 ~ _ ~.=_ SUBJECT M =oo $oo RIA >loo -4 t I u ~ ~o / ' i ~''~-'~ D't,.4~. EMIT RATE :iit-.._.,_ - _,, T,,, ~,,,,,,,,,,,,, i i i, i i r i i i ~,C/M5 soo SUBJECT N ,oo RIA ~) ~oo I A ~, o g,,, 4, 4t,*,, EMIT RATE 5~o 173

6 produced overall results similar to the assay profiles of cannabinoid excretion by EMIT 20 Assay and Abuscreen RIA (see Figure 2). With a cutoff of 5 ng/ml of THCCOOH, mean times _+ SE to first negative were h and h and mean times +SE to last positive were 149.0_+36.2 h and h after administration of the low and high marijuana brownie doses, respectively (Table IV). Individual peak concentrations of total THCCOOH varied from 108 to 325 ng/ml (mean _+ SE = 180 _+ 39 ng/ml) and 177 to 436 ng/ml (mean SE = 312 +_ 48 ng/ml) after administration of the low and high marijuana brownie doses, respectively. Estimation of the cumulative dose of total THCCOOH excreted in urine as a percentage of total THC and THC acid B administered also are shown in Table IV. The mean amount of total THCCOOH excreted after both marijuana doses was 1.3% of the administered dose. Discussion The administration of marijuana-laced brownies to male human subjects resulted in the production of behavioral and physiologic effects similar to those produced when subjects actively smoked marijuana cigarettes (7). In addition, substantial amounts of cannabinoid metabolites and THCCOOH were excreted in urine. Unlike the smoking route in which peak behavioral and physiologic effects occur within minutes after smoking (5), responses after ingestion of marijuana had a slower onset and greater variability with maximum effects occurring 1.5 to 3.5 h later. This slow onset of effects is consistent with results reported in other time-action studies in humans after oral administration of THC in 5 different vehicles (8), THC deposited on a chocolate cookie (5), and cannabis resin in a meat sandwich (3). A number of factors are likely to determine individual response to thc oral administration of marijuana plant material. These factors include the initial dose of THC and THC precursor acid, the degree of conversion of THC precursor acid to THC prior to ingestion, the rate of absorption of THC from the gastrointestinal system, and degree of first-pass metabolism of THC. Perez-Reyes et al. (8) reported that the speed and degree of absorption of THC are greatly influenced by the vehicle used for administration, but also presented convincing evidence based on cumulative urinary excretion data over 72 h that only the rate of absorption of THC was affected by the nature of the vehicle and not degree of absorption. Subjects in the present study were allowed unrestricted access to food and drink as commonly occurs in social situations. It is possible that fasting prior to consumption of the marijuana-laced brownies would have increased the rate of absorption of marijuana constituents and reduced intersubject variability. It is clear from the estimated cumulative excretion amounts of total THCCOOH in urine, however, that the amount of THC absorbed from the two active marijuana doses by each subject was not a major source of variability (see Table IV). Conversion of THC precursor acids to THC by heat during marijuana smoking (11) presumably results in activation and increased potency. Whether this process occurred at the lower temperatures employed in the preparation of brownies is open to speculation; however, due to the robust behavioral effects indicated on the Feel Drug scale and the substantial amounts of THCCOOH and cannabinoid metabolites excreted in urine, it seems likely that activation did occur. An additional factor contributing to the variability in behavioral and physiologic responses after oral ingestion of marijuana is the potential metabolic production of the active metabolite of THC, ll-hydroxy-thc (II-HO-THC). The metabolism of THC initially involves hydroxylation of the allylic methyl groups of THC to 11-HO-THC followed by oxidation to THCCOOH and conjugation. The presence of the active metabolite, 11-HO-THC, in blood is generally low (ca. 1:10 ratio to THC) after intravenous infusion of THC; however, after oral ingestion the amount of I I-HO-THC can nearly equal THC levels (4). Since the pharmacologic activity of 1 I-HO-THC equals or exceeds that of THC (9), it is likely that this metabolite contributes to the pharmacological activity of orally administered marijuana. The individual urinary excretion profiles of THCCOOH and cannabinoid metabolites of subjects who ingested marijuanalaced brownies in the present study were similar to those reported by Law et al. (3) for humans who consumed cannabis resin in a meat sandwich. In the latter study, subjects ingested cannabis resin containing a total of 20 mg THC. Metabolites of THC were detected by RIA up to 12 days after drug administration. Consumption of marijuana-laced brownies con- Table III. EMIT d.a.u. Assay of Specimens from Subjects Who Ingested Marijuana-Laced 20-nglmL cutoff Brownies 75-nglmL cutoff Dose equivalent Time to first Time to last Time to first Time to last Subject (cigarettes) negative (h) positive (h) negative (h) positive (h) H K , L , , M N Mean:l:SE t t :1: :t: ,1 82,6 174

7 Table IV. GC/MS and Abuscreen RIA Assay of Specimens from Subjects Who Ingested Marijuana-Laced Brownies GCIMS* Dose THCCOOH RIA ~ equivalent Time to first Time to last Peak concn Time to peak Cumulative Time to first Time to last Subject (cigarettes) negative (h) positive (h) (nglml) conch (h) dose (%) negative (h) positive (h) H K L M N Mean +SE * Cutoff = 5 ng/ml THCCOOH. "* Cutoff = 10 nglml THCCOOH equivalents. taining the equivalent of 22.4 mg THC (plant material of one marijuana cigarette) by subjects in the present study resulted in excretion of detectable amounts of cannabinoid metabolites for approximately 6 days (range 3-11 days, Tables 111 and IV). After their consumption of brownies containing the equivalent of 44.8 mg THC (plant material of two marijuana cigarettes), the same subjects excreted cannabinoid metabolites for slightly longer periods of time (range days). The prolonged excretion of total THCCOOH in urine is consistent with recently reported kinetic parameters for this metabolite. The elimination half-life for THCCOOH and its glucuronide in blood of human subjects who ingested cannabis was 22 h and 21 h, respectively (3). These values are strikingly similar to the elimination half-life of 25 h for THC in blood after oral administration (4) and allow the possibility that redistribution of THC from adipose tissue back into circulation and subsequent hepatic metabolism is the rate-limiting step in the urinary excretion of THC metabolites and that urinary excretion of total THCCOOH is a rapid process. If so, oral ingestion of marijuana would be expected to initially produce a surge of total THCCOOH, eliminated by first pass metabolism, and followed by a steady elimination similar to that observed after marijuana smoking. The individual excretion profiles of total THCCOOH in this study are consistent with this interpretation. These data also lend credence to the suggestion by Law et al. (3) that ingestion of a pharmacologically subactive dose of marijuana could result in initial excretion of detectable levels of cannabinoid metabolites. In addition, the assay of urine specimens in this study by 3 different methodologies (EMIT d.a.u., Abuscreen RIA, and GC/MS) allows comparison of the performance of these assays. Assay by EMIT 20 provided slightly shorter detection times (first negative, last positive) than Abuscreen RIA; however, a higher cutoff (20 ng/ml of THCCOOH equivalents) was used in the former assay. It seems likely that nearly equal detection times would be obtained by EMIT if the same cutoff had been employed in both assays. Detection times by GC/MS were between EMIT 20 Assay and Abuscreen RIA. When used for confirmation of cannabinoid metabolites at cutoff levels of 20 ng/ml, GC/MS clearly provided sufficient sensitivity and detection times for quantitative determination of total THCCOOH in most cannabinoid-positive specimens. Acknowledgments Special thanks are given to P. Welch (LPN I1) and S. Menchen (MT) for technical assistance. References 1. L. Lemberger and A. Rubin. The physiologic disposition of marijuana in man. Life Sci. 17: (1975). 2. M.E. Wall and M. Perez-Reyes. The metabolism of Ag-tetrahydro - cannabinol and related cannabinoids in man. J. C/in. Pharmaco/. 21: 178S-189S (1981). 3. B. Law, P.A. Mason, A.C. Moffat, R.I. Gleadle, and L.J. King. Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin. J. Pharm. Pharmaco/. 36: (1984). 4. M.E. Wall, B.M. Sadler, D. Brine, H. Taylor, and M. Perez-Reyes. Metabolism, disposition and kinetics of Ag-tetrahydrocannabinol in men and women. C/in. Pharmaco/. Ther 34: (1983). 5. A. Ohlsson, J.-E. Lindgren, A. Wahlen, S. Agurell, L.E. Hollister, and H.K. Gillespie. Plasma Ag-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. C/in, Pharmaco/. Ther. 28: (1980). 6. B.D. Paul, L.D Mell, Jr., JM. Mitchell, R.M. McKinley, and J. Irving. Detection and quantitation of urinary 11-nor-Ag-tetrahydrocannabinol-9-carboxylic acid, a rnetabolite of tetrahydrocannabinol, by capillary gas chromatography and electron impact mass fragrnentography. J. Ana/. Toxico/. 11:1-5 (1987). 7. E.J. Cone, R.E. Johnson, J.D. Moore, and J.D. Roache. Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects. Pharmaco/., Biochem. Behav. 24: (1986). 8. M. Perez-Reyes, M.A. Lipton, M.C. Timmons, M.E. Wall, D.R. Brine, and K.H. Davis. Pharmacology of orally administered Ag-tetrahydrocannabinol. C/in. Pharmaco/. Ther. 14:48-55 (1973). 9. L. Lemberger and A. Rubin. The physiologic disposition of marijuana in man. Life Sci. 17: (1975). 10. E.J. Cone and R.E. Johnson. Contact Highs and Urinary Cannabinoid Excretion After Passive Exposure To Marijuana. C/in. Pharmaco/. Ther 40: (1986). 11. U. Claussen and F. Korte. Uber das Verhalten von Hanf und von Ag-6a.lOa-trans-Tetrahydmcannabinol biem Rauchen. Liebigs Ann. Chem. 713: (1968). Manuscript received September 8, 1987; revision received December 31,